Αποτελέσματα Αναζήτησης
15 Σεπ 2020 · Drug-Induced Bradyarrhythmias. Bradyarrhythmias are broadly classified as sinus node dysfunction and atrioventricular block. Drugs that inhibit sinus node function can cause sinus bradycardia (heart rate <60 bpm), sinus pauses, or sinus arrest (Supplemental Figure 1).
- Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings
Background and Purpose:This scientific statement provides an...
- Digitalis
Abstract—Cardiac glycosides have played a prominent role in...
- 2018 Acc/Aha/Hrs Guideline on The Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay
Negative chronotropic drugs such as beta blockers, calcium...
- Pdf/Epub
PK r«Xoa«, mimetypeapplication/epub+zipPK r«X...
- Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings
The main findings of this retrospective analysis were that about one quarter of the DRB was not caused by, but revealed by drugs, and that beta-blockers were the most common 'offending' drug involved in the development of bradycardia. Does drug-related bradycardia suggest a benign prognosis?
21 Σεπ 2020 · Bradycardia: Sinus node automaticity is suppressed by drugs that inhibit sympathetic nervous system activity (beta-blockers) or stimulate the parasympathetic nervous system (neostigmine, pyridostigmine).
28 Δεκ 2021 · Stimulants including cocaine and methamphetamine can produce damaging cardiovascular effects and initiate and perpetuate various arrhythmias. Expert consensus statements and guidelines do not specifically address this issue.
20 Ιουν 2018 · 1. Introduction. Toxicomania is a worldwide health and social problem. In 2015, the World Health Organization estimates that 255 millions of people are drug users and more than 10% of them have health disorders [1].
In the majority of patients with drug-induced bradycardia, the only treatment required is withdrawal of the offending drug. Common cardiac drugs that may cause bradycardia include β-blockers, CCBs, digoxin, and class I and III antiarrhythmics.
A study by Lee, et al. found that β-blockers were the most common drugs associated with drug-related bradycardia (DRB). In this study, drug discontinuation was followed by resolution of bradycardia in 60% of patients.
